Events

This live facilitated two-part course provides clinicians the knowledge and confidence to prescribe gender affirming hormone therapy (GAHT) based on the needs of their patient population utilising an informed consent model.

Date Venue Organiser Learning Outcomes TOPIC 1. Risk: Identify who needs to be screened for prostate cancer Discuss how to interpret borderline PSA levels and indications for specialist referral TOPIC